Merck & Co. Inc. (MRK)

$ 127.51
   
  • Change Today:
    $-0.75
  • 52 Week High: $131.95
  • 52 Week Low: $100.18
  • Currency: US Dollars
  • Shares Issued: 2,531.63m
  • Volume: 6,221,928
  • Market Cap: $322,808m
  • RiskGrade: 92
  • Beta: 0.32

Merck Overview

US drugmaker, Merck & Co, is a leading global research-driven pharmaceutical products and services company. The company discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Its products, generally sold by prescription, include therapeutic and preventive agents for the treatment of human disorders and animal health supplies. The company’s products are sold, primarily, to drug wholesalers and retailers, hospitals, clinics, government agencies and managed healthcare providers, such as health maintenance organisations and other institutions.

1 Day Chart (03-05-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Merck Financials

Latest F'cast
Div Yield 2.3%
Div Cover 0.0
Op Mrgn 3.1%
ROCE 5.6%
Latest F'cast
P/E 910.8
PEG n/a
Pr/Revenue 5.4
Pr/Book 8.6
Latest F'cast
Revenue 1.4%
PBT -88.5%
EPS -97.6%
DPS 5.7%

Merck Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 46,840.00 11,464.00 384.00¢ 23.7 0.4 +64% 226.00¢ 2.5%
31-Dec-20 47,994.00 8,791.00 179.00¢ 45.7 n/a -53% 248.00¢ 3.0%
31-Dec-21 48,704.00 13,879.00 488.00¢ 15.7 0.1 +173% 264.00¢ 3.4%
31-Dec-22 59,283.00 16,444.00 573.00¢ 19.4 1.1 +17% 280.00¢ 2.5%
31-Dec-23 60,115.00 1,889.00 14.00¢ 778.7 n/a -98% 296.00¢ 2.7%

Merck Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 63,936.57 25,841.22 858.46¢ 14.9 0.0 +6,032% 322.20¢ 0.0%
31-Dec-25 68,320.55 29,573.21 984.87¢ 12.9 0.9 +15% 345.66¢ 0.0%
31-Dec-26 71,976.34 31,975.97 1,084.30¢ 11.8 1.2 +10% 369.94¢ 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Merck ShareCast News

US close: Stocks recover from three days of losses 28-Mar-2024 ShareCast
US close: Stocks bounce back as labour market so... 02-Feb-2024 ShareCast
Moderna shares surge on cancer trial combo with ... 14-Dec-2023 ShareCast

Merck Top Newspaper Links

Merck increases antibiotic offering with $9.5bn ... 09-Dec-2014 Telegraph
Reckitt Benckiser bows out of race for Merck's c... 01-May-2014 Telegraph
Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Merck Market Data

Currency US Dollars
Share Price $ 127.51
Change Today $ -0.75
% Change -0.58 %
52 Week High $131.95
52 Week Low $100.18
Volume 6,221,928
Shares Issued 2,531.63m
Market Cap $322,808m
Beta 0.32
RiskGrade 92

What The Brokers Say

Strong Buy 11
Buy 11
Neutral 3
Sell 0
Strong Sell 0
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 03-May-2024

Time Volume / Share Price
16:00 100 @ $127.52
16:00 1,033,938 @ $127.51
15:59 4,300 @ $127.51
15:59 289 @ $127.51
15:59 512 @ $127.51

Top of Page